Skip to main content
. 2022 Jun 26;13(5):13986–13999. doi: 10.1080/21655979.2022.2085284

Figure 6.

Figure 6.

Role of NXPH4 in immunotherapeutic responses. (a-b) The association between ICIs and NXPH4. (c-f) The correlation between immunophenoscore and different NXPH4 expression groups. (g-j) Low NXPH4 expression group was positively associated with a higher IC50 of Doxorubicin, Gemcitabine, Tipifarnib, and Methotrexate.